These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33322926)

  • 1. Evaluation of the Efficacy and Safety of an eGlycemic Management System in a Community Hospital Setting.
    Bouldin MG; Hong B; Setji T; Greenlee J; Cooper A; Thompson J; Capes K
    J Diabetes Sci Technol; 2021 Mar; 15(2):236-241. PubMed ID: 33322926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
    Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
    J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System.
    Newsom R; Patty C; Camarena E; Sawyer R; McFarland R; Gray T; Mabrey M
    J Diabetes Sci Technol; 2018 Jan; 12(1):53-59. PubMed ID: 29237289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
    Rabinovich M; Grahl J; Durr E; Gayed R; Chester K; McFarland R; McLean B
    J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL.
    Tanenberg RJ; Hardee S; Rothermel C; Drake AJ
    Endocr Pract; 2017 Mar; 23(3):331-341. PubMed ID: 27967226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of the Use of an Electronic Glucose Monitoring System Versus Weight-Based Dosing Nomogram for Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome in a VA Hospital.
    Brown M; Roberts J; Smith C; Eash D
    J Diabetes Sci Technol; 2023 May; 17(3):727-732. PubMed ID: 35128975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of "Comparison an Electronic Glycemic Management System Versus Provider Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting".
    Leitgeb S; Mader JK
    J Diabetes Sci Technol; 2017 Jan; 11(1):17-19. PubMed ID: 28264175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Initial eGlycemic Management System Dosing Strategy on Time to Target Blood Glucose Range.
    Emamdjomeh AS; Warren JN; Harper CL; Olin JL
    J Diabetes Sci Technol; 2021 Mar; 15(2):242-250. PubMed ID: 33588608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving IV insulin administration in a community hospital.
    Magee MC
    J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a pharmacist-managed protocol for the transition from intravenous to subcutaneous insulin in critically ill adults.
    Gerhardt JM; Dine SA; Foster DR; Lodolo AC; McIntire AM; Peters MJ; Rhew TA; Walroth TA
    Am J Health Syst Pharm; 2022 Aug; 79(Suppl 3):S86-S93. PubMed ID: 35605142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis.
    Ullal J; Aloi JA; Reyes-Umpierrez D; Pasquel FJ; McFarland R; Rabinovich M; Umpierrez GE
    J Diabetes Sci Technol; 2018 Jan; 12(1):39-46. PubMed ID: 29291648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
    Bellido V; Suarez L; Rodriguez MG; Sanchez C; Dieguez M; Riestra M; Casal F; Delgado E; Menendez E; Umpierrez GE
    Diabetes Care; 2015 Dec; 38(12):2211-6. PubMed ID: 26459273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms.
    Newton CA; Smiley D; Bode BW; Kitabchi AE; Davidson PC; Jacobs S; Steed RD; Stentz F; Peng L; Mulligan P; Freire AX; Temponi A; Umpierrez GE
    J Hosp Med; 2010 Oct; 5(8):432-7. PubMed ID: 20945468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
    Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
    Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EATING AND GLYCEMIC CONTROL AMONG CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS INTRAVENOUS INSULIN.
    Miller EE; Lalla M; Zaidi A; Elgash M; Zhao H; Rubin DJ
    Endocr Pract; 2020 Jan; 26(1):43-50. PubMed ID: 31461360
    [No Abstract]   [Full Text] [Related]  

  • 16. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients.
    Franchin A; Maran A; Bruttomesso D; Corradin ML; Rossi F; Zanatta F; Barbato GM; Sicolo N; Manzato E
    Aging Clin Exp Res; 2017 Dec; 29(6):1087-1093. PubMed ID: 28238154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAFETY AND EFFICACY OF GLUCOSTABILIZER IN THE MANAGEMENT OF DIABETIC KETOACIDOSIS.
    Groysman AY; Peragallo-Dittko V; Islam S; Klek S
    Endocr Pract; 2020 Jun; 26(6):627-633. PubMed ID: 31968186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical intensive care unit patients with hyperglycemia: is it possible a hypoglycemic risk close to zero?].
    Cosmi F; Mariottoni B; Cosmi D
    G Ital Cardiol (Rome); 2018; 19(7):460-466. PubMed ID: 29989603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.
    Umpierrez GE; Gianchandani R; Smiley D; Jacobs S; Wesorick DH; Newton C; Farrokhi F; Peng L; Reyes D; Lathkar-Pradhan S; Pasquel F
    Diabetes Care; 2013 Nov; 36(11):3430-5. PubMed ID: 23877988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
    Pasquel FJ; Lansang MC; Khowaja A; Urrutia MA; Cardona S; Albury B; Galindo RJ; Fayfman M; Davis G; Migdal A; Vellanki P; Peng L; Umpierrez GE
    Diabetes Care; 2020 Jun; 43(6):1242-1248. PubMed ID: 32273271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.